Welcome!

The Maryland and District of Columbia Society of Clinical Oncology, Inc. (“MDCSCO”) is committed to improving the quality and delivery of care in medical oncology in the State of Maryland and the District of Columbia. We promote appropriate standards of care in oncology and cooperate with investigators conducting cancer research.

In addition, we assist in the continuing education of oncologists and educate the public, the government, insurance carriers, and other health care providers about appropriate prevention of cancer and other therapeutic options for patients with cancer.

We encourage you to join more than 400 current members in providing the leadership in our progressive future. Click here to find out more about our membership.


Click to see the latest News & Publications

VIEWBOOK

Membership Benefits

Membership is Now FREE for
Professional
Members and for Allied
Professionals.

Click here to join!

 

IMPORTANT NOTICE TO ONCOLOGISTS

NO MORE DUES!

The Maryland and District of Columbia Society of Clinical Oncology now offers FREE professional memberships to physician oncologists. Click here for the flyer.

As a member, you get the following benefits:

  • Free attendance at ALL MDCSCO events.
  • A legislative voice on issues of high priority to the practice of oncology.
  • Being a member of one of the U.S.'s strongest ASCO state affiliates and representation at ASCO.
  • Representation at NCCN.
  • Opportunity to be considered for elected office and other leadership roles within MDCSCO.

Confirm your membership now!

 

New ASCO Policy Brief: Co-Pay Accumulators and Co-pay Maximizers
Co-pay accumulators and co-pay maximizers have been an area of concern amongst State Affiliate Council members.  ASCO has created a new informational policy brief to help explain these programs and provide guidance regarding its position as an organization.  The brief can be accessed by clicking below.

Click here for more information

Report: Progress in Global Cancer Fight is Not Only Possible, but Achievable
The Cancer Atlas, 3rd edition, a comprehensive global overview of cancer around the globe, concludes that progress in the fight against cancer is not only possible, but achievable.

Find out more
Cancer Drugs Account for 27% of All New Drug Approvals in the US

Cancer drugs currently account for 27% of all new drug approvals in the United States since 2010, a dramatic increase from the 4% share of the 1980s, a newly completed analysis from the Tufts Center for the Study of Drug Development shows.

Click here for more

Sharing Hospital Outpatient Payment Proposal Maintains 340B Cuts, Addresses Price Transparency and Prior Authorization
On July 29, the Centers for Medicare & Medicaid Services (CMS) released its proposed rule for reimbursement under the Hospital Outpatient Prospective Payment System (HOPPS) in 2020. ASCO is still analyzing the proposal and will provide more information to members as soon as possible.

Click here for more.

CMS' "Fail First" Step Therapy Policy Means Medicare Patients with Cancer Will Face More Dangerous Delays and Denials
Earlier this month, the Centers for Medicare & Medicaid Services (CMS) codified its decision to allow MA plans to use “fail first” step therapy for new starts of Part B drugs for cancer and other serious diseases. The Trump administration’s decision to finalize step therapy in MA plans means that Medicare patients with cancer will face nightmares of delays and denials while trying to access their physician-prescribed treatments

Click here for more.

 

MDCSCO October 24, 2018
Membership and Awards Dinner
Award Recipient Sheila Ross

UPCOMING MEETINGS

2019 Membership Dinner
October 30, 2019
Reception: 6:15 p.m.
Dinner: 7:15 p.m.
The Center Club
100 Light Street
16th Floor
Baltimore, Maryland

FREE for MDCSCO members and prospective members

Speaker: Joanne Ebner, BSN, OCN, C-TTS
Manager, Cancer Prevention Department
Anne Arundel Medical Center

Award Presentation:
Legislative Achievement Award
The Honorable Dereck Davis
Chair, Maryland House Economic Matters Committee
For sponsorship of HB1169
raising the minimum smoking and vaping age to 21

Note:
Free parking is available for attendees.
Charles Street, just north of Pratt Street
Watch for small Center Club sign on right
Bring photo ID for garage admission
Go to Lower Level and use Center Club parking
Use elevators from garage; look for Center Club Elevator
Go to 16th floor.

Exhibitor Online Registration - Click here.

Exhibitor Registration - PDF form

Members - Click here to register


2019 - SAVE THE DATES!

(See the event calendar for more info!)

October 30 - MDCSCO Awards Dinner, Baltimore, Center Club

December 4 - MDCSCO Industry Spotlight, Hanover, MD - Hotel at Arundel Preserve
December 7 - 9 – ASH Annual Meeting


ANNOUNCEMENTS


United Health and Optum 'Uniting Care and Coverage' in New Model
UnitedHealth Group and its Optum medical care provider business are rolling out a combined package of medical care and health insurance as they meld health benefits with the provision of healthcare services.

Find out more

New Survey Seeks Provider Input on Clinical Trial Enrollment
ASCO is participating in a joint initiative from the American Cancer Society's Cancer Action Network in conjunction with the Association of Community Cancer Centers and the Oncology Nursing Society.  Click below to access the survey.

Click here for the survey

Walmart to Measure Doctor Quality in Local Markets
Walmart is rolling out an effort to measure the quality of community doctors who treat tens of thousands of its employees in the retailer’s latest effort to make sure its workers get the right care, in the right place and at the right time.

Find out more

CMS to Collect 340B Drug Cost Information
The CMS issued a notice on September 26th that it will collect information from hospitals participating in the 340B drug discount program about the prices they pay for eligible drugs.

Click here for more
Educate and Support Your Patients with ASCO Answers Materials

Recently, State Affiliate presidents and executive directors received a mailing from Cancer.Net that included patient education materials that you and your members may find useful. These materials, along with additional resources that can be found on Cancer.Net give your patients ASCO-approved information on diagnosis, treatment, side effects, and psychosocial effects of cancer.  The ASCO Answers series includes fact sheets, booklets on specific topics in cancer care, and comprehensive, patient-friendly guides. These easy-to-read materials cover breast cancer, colorectal cancer, non-small cell lung cancer, small cell lung cancer, prostate cancer, cancer survivorship, caregiving, palliative care, managing cancer-related pain, advanced cancer care planning, and much more.  ASCO members save 20 percent.  All orders include free domestic shipping. 

Order printed copies online at the ASCO Store.

New Technology Add-on Payment: Impact on CAR T-cell Therapy Reimbursement
On August 2, the Centers for Medicare & Medicaid Services (CMS) released the Hospital Inpatient Prospective Payment System (IPPS) final rule for fiscal year (FY) 2020.

Click here for more.

CMS Expands CAR T-cell Therapy Coverage for Medicare Beneficiaries
The Centers for Medicare & Medicaid Services (CMS) announced that Medicare will now cover all Food and Drug Administration-approved Chimeric Antigen Receptor T-cell (CAR T-cell) therapy delivered in inpatient facilities.  This nationwide Medicare coverage increase for CAR T-cell therapy also opens the door for patients to receive treatment in outpatient health care facilities that are enrolled in FDS risk evaluation and mitigation strategies with expertise in delivering cellular therapies, and covers CAR T-cell therapy for off-label uses that are recommended by CMS-approved compendia.

Read more here